Differences Between Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC)
PBC predominantly affects middle-aged women with small intrahepatic bile ducts and is diagnosed by positive antimitochondrial antibodies, while PSC primarily affects young men with inflammatory bowel disease, involves both intra- and extrahepatic bile ducts, and requires cholangiography showing multifocal strictures for diagnosis. 1, 2, 3
Demographics and Patient Profile
PBC:
- Occurs predominantly in women (>90% of cases) 3
- Typical age: 40-70 years (fourth to seventh decades) 4
- No association with inflammatory bowel disease
- Male to female ratio strongly favors females
PSC:
- Occurs primarily in young men (male to female ratio 2:1) 1, 5, 2
- Mean age at diagnosis: around 40 years 5
- 70-80% have concomitant inflammatory bowel disease, predominantly ulcerative colitis 4, 1, 5
Anatomic Distribution
PBC:
- Affects small intrahepatic bile ducts (interlobular bile ducts) 4
- Extrahepatic bile ducts remain normal on imaging 3
- May show smooth tapering and narrowing of intrahepatic ducts occasionally 3
PSC:
- Affects both intrahepatic AND extrahepatic bile ducts 1, 5, 2
- Characterized by multifocal strictures and dilatations 2
- In ~10% of cases, limited to peripheral ductules (small duct PSC) 2
Diagnostic Approach
PBC Diagnosis:
- Antimitochondrial antibodies (AMA) positive - always present, usually in very high titer 3
- Elevated alkaline phosphatase and cholestatic pattern
- Liver biopsy shows florid duct lesion (diagnostic when present) 3
- Cholangiography shows normal extrahepatic ducts 3
PSC Diagnosis:
- Antimitochondrial antibodies nearly always negative 3
- Cholangiography (MRCP preferred) shows multifocal bile duct strictures - required for diagnosis 6, 1, 2
- Liver biopsy often compatible but usually not diagnostic; shows periductal fibrosis 2, 3
- p-ANCA positive in 26-96% but lacks diagnostic specificity 2
Clinical Presentation
Common to Both:
- Fatigue and pruritus are frequent symptoms 1, 3
- Elevated alkaline phosphatase 1
- May be asymptomatic at diagnosis (50% in PSC, 25% in PBC) 1
PBC-Specific:
- Keratoconjunctivitis sicca commonly present 3
- Hyperpigmentation often noted 3
- Symptoms rare in early disease 4
PSC-Specific:
- Right upper quadrant pain more common 1
- Episodes of fever and chills (cholangitis) 5
- Symptoms related to inflammatory bowel disease 1
Malignancy Risk
PBC:
- Rarely develops cholangiocarcinoma 7
- Lower overall cancer risk compared to PSC
PSC:
- Substantially increased risk of cholangiocarcinoma (10-15% lifetime risk) 4, 1
- Increased risk of colorectal cancer (due to IBD association) 4, 1
- Cholangiocarcinoma discovery dramatically reduces transplant survival 4
- Regular colonoscopy surveillance mandatory in those with ulcerative colitis 4
Treatment
PBC:
- Ursodeoxycholic acid is first-line therapy with proven benefit 8, 9, 10
- Second-line agents: obeticholic acid, seladelpar, elafibranor, or fibrates 9, 10
- 70% of patients survive at least 10 years after transplantation 4
PSC:
- No approved medical therapy proven to improve survival 4, 1, 5, 8, 9
- Ursodeoxycholic acid at doses >28 mg/kg/day associated with increased mortality and should be avoided 11, 12
- Endoscopic treatment of dominant strictures with balloon dilation 6, 13
- Prophylactic antibiotics recommended before ERCP 6
- Liver transplantation is the only definitive treatment 4, 13
Prognosis and Natural History
PBC:
- Very long course, often decades 14
- Excellent survival after transplantation (>90% at 1 year, ~85% at 3 years) 4
- Recurrent PBC after transplantation documented but minimal impact on long-term survival 4
PSC:
- Most patients with symptomatic disease develop liver failure within 10-12 years 4
- Variable natural history 4
- 3-year survival after transplantation >90% 4
- Recurrent disease common after transplantation 4
Key Diagnostic Pitfalls
Critical distinctions to avoid misdiagnosis:
- Always check AMA in cholestatic patients - positive essentially confirms PBC 3
- Normal cholangiography does NOT exclude PSC - consider small duct PSC variant requiring liver biopsy 2
- IgG4-related sclerosing cholangitis can mimic PSC - check serum IgG4 levels and consider bile duct wall thickening >2.5mm on MRI 2
- PBC-PSC overlap syndrome exists but is extremely rare 15
- Secondary causes of sclerosing cholangitis must be excluded before diagnosing PSC 1, 2